Skip to main content Start main content
Dr Raymond Yeung

Dr Raymond Yeung

Professor of Practice (Biotechnology)

Research Overview

I am interested in understanding the factors and mechanisms that influence the productivity and efficiency of the drug research and development process.

Education and Academic Qualifications

  1. Ph.D., University of South Australia, Division of Business, International Graduate School of Business, Australia (2017)
  2. MBA, California State University, Hayward, USA (2004)
  3. M.Sc. in Biomedical Science (Medical Microbiology), University of the West of England (UWE Bristol), UK (1998)
  4. B.Sc. (Economics), University of London, UK (1993)
  5. Graduate Diploma in Management Research, University of South Australia, Division of Business,
    International Graduate School of Business, Australia (2009)
  6. Graduate Certificate in International Arbitration, Faculty of Law, National University of Singapore (2018)
  7. Higher Certificate in Medical Laboratory Technology, Hong Kong University (1979)

Professional Qualifications

  1. Fellowship of the Institute of Biomedical Sciences, United Kingdom
  2. Advanced Certificate in Medical Laboratory Technology (Medical Microbiology), Canadian Society of Laboratory Technologists, Canada
  3. Certificate of Registration, College of Medical Laboratory Technologists of Ontario, Canada

Academic and Professional Experience

  1. Avalon Biomedical (Management) Ltd.
    • Executive Vice President (2019 – 2021)
    • Senior Vice President, Operations and R&D (2018 - 2019)
    • Vice President, Operations and R&D (2015 – 2018)
  2. Emerging Viral Research Ltd.: President (2015 – 2021)
  3. Athenex Inc., USA: General Manager, Athenex Hong Kong (2017 – 2021) and Senior Director & Deputy Head, Clinical Research and Regulatory Affairs, Asia-Pacific (2016 – 2021)
  4. Fortune Pharmacal, Hong Kong: General Manager (2012 – 2015)
  5. Albany Molecular Research Inc. (AMRI), Singapore Research Center (now Curia Global Inc.): Managing Director (2007 – 2011)
  6. MDS Inc. and MDS Pharma Services, Canada & Singapore: Director, Asia Pacific, MDS Pharma Services, Singapore (2002 – 2006)

Research Interests

  • Productivity and Efficiency of Drug Research & Development
  • Application of Artificial intelligence in biotech and pharma industries
  • Therapeutic Vaccine
  • Quality Assurance
  • Regulatory Affairs
  • Ethics
  • Pharmacoeconomics
  • Arbitration and Dispute Resolution

Achievements

  1. Prevalence and Mechanisms of Macrolide Resistance in Clinical Isolates of Group A Streptococci from Ontario, Canada. J. C. S. De Azavedo, R. H. Yeung, D. J. Bast, C. L. Duncan, S. B. Borgia, and D. E. Low Antimicrob. Agents Chemother. 1999 43: 2144-2147.
  2. Prevalence and Mechanisms of Macrolide Resistance in Clinical Isolates of S. pneumoniae, Streptococci of the Viridans Group and Group A Streptococci (GAS).J C S de Azavedo, N J Johnston, P Chang, R Yeung, S Tyler, M Coulthart, W Johnson and D E Low. Streptococcal Meeting, France, Jan. 1998.
  3. Comparison of the Seasonal Incidence of Cyclospora cayatenensis and Cryptosporidium parum in Routine Faecal Examinations over 3 years. General Meeting; American Society for Microbiology; 1997 May 4-9; Miami Beach (FL). Report No.:C-223. J Palmer, R Bleicher, B Gandhi, and R. Yeung.
  4. Reproducibility and accuracy of different testing methods for determining the susceptibility of Streptococcus pneumoniae. Canadian Association of Clinical Microbiology and Infectious Diseases (CACMID) Poster, Nov 1995, B Gandhi, R Yeung, G Small, P Lo, M Skulnick, D Low, S Matsumura
  5. Efficacy of Multiple Specimens for the Recovery of Parasites in a Community-based Laboratory. ASM Poster, 1995. S Finn, P Foltas, S Murdock, S E Farhat, R Yeung, E Molina-Bravo, D Gopaul, D Diena, B B Diena.
  6. Use of a Single Combined Direct and Washed Smear for the Detection of Cryptosporidium oocysts. ASM Poster, 1994. S Finn, S Murdock, P Foltas, R Yeung, B Diena and D Diena.
  7. Use of a Combined Direct and Washed Smear in the Detection of Cryptosporidium oocysts. Letter to the Editors. Finn S, R Yeung, P Foltas, S Murdock. Clin Microbiol Newsletter 1992;14:191-192.
  8. Isolation and identification of halophilic vibrios. (Letter) Ng E Y L, Yeung H T, Simon M T P. Med Lab Sci 1985;42:104-105
  9. An improved medium for the isolation and rapid identification of group B streptococci in female genital tract specimens. Ng E Y L, Yeung H T. Aust J Med Lab Sci 1983;3:11-14.
  1. Devices and Methods for Enhancing Immunogenicity to Intradermal Vaccination, United States Provisional Application No. 62/419,895 filed on November 9, 2016, R Yeung, C Lau, JYL Lau, I Hung, KY Yuen.
  2. Methods and Compositions for Enhancing Immunogenicity of Vaccine, United States Provisional Application No. 63/015483 filed on April 25, 2020, Kang Zhang, Manson Fok, Raymond Yeung, Johnson Yiu-Nam Lau, Kwok-Yung Yuen.

Your browser is not the latest version. If you continue to browse our website, Some pages may not function properly.

You are recommended to upgrade to a newer version or switch to a different browser. A list of the web browsers that we support can be found here